Oncternal Therapeutics In... (ONCT)
NASDAQ: ONCT
· Real-Time Price · USD
0.53
-0.16 (-23.63%)
At close: Dec 02, 2024, 10:00 PM
Oncternal Therapeutics Revenue
Oncternal Therapeutics reported an annual revenue of $785K, reflecting a -47.32% growth. For the quarter ending September 30, 2024, Oncternal Therapeutics generated $0 in revenue.
Revenue (ttm)
785K
Revenue Growth
-47.32%
Price / Sales Ratio
40.15
Revenue / Employee
29.07K
Employees
27
Market Cap
1.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2023 | 785K | -47.32% |
| Dec 31, 2022 | 1.49M | -65.47% |
| Dec 31, 2021 | 4.32M | +27.85% |
| Dec 31, 2020 | 3.38M | +39.18% |
| Dec 31, 2019 | 2.42M | -3.81% |
| Dec 31, 2018 | 2.52M | +50.60% |
| Dec 31, 2017 | 1.67M | +-166.67% |
| Dec 31, 2016 | -2.51M | -Infinity% |
| Dec 31, 2015 | 0 | n/a |
| Dec 31, 2014 | 0 | n/a |
| Dec 31, 2013 | 0 | n/a |
| Dec 31, 2012 | 0 | -100.00% |
| Dec 31, 2011 | 14.74M | -75.68% |
| Dec 31, 2010 | 60.61M | +311.49% |
| Dec 31, 2009 | 14.73M | +8.89% |
| Dec 31, 2008 | 13.53M | +89.84% |
| Dec 31, 2007 | 7.13M | -5.05% |
| Dec 31, 2006 | 7.5M | +98.44% |
| Dec 31, 2005 | 3.78M | +102.57% |
| Dec 31, 2004 | 1.87M | +Infinity% |
| Dec 31, 2003 | 0 | n/a |
| Dec 31, 2002 | 0 | n/a |
| Dec 31, 2001 | 0 | n/a |
| Dec 31, 2000 | 0 | n/a |
| Dec 31, 1999 | 0 | n/a |